The TRADE

JULY 11, 2023

.” The review consists of seven recommendations including the introduction of a Research Platform, which will provide a central facility for the promotion, sourcing and dissemination of research on publicly traded companies – potentially open to all, but in particular, for smaller cap companies.

Asset Management 40

Asset Management Investment Government Capital Market 40

Software Equity Group

OCTOBER 22, 2024

WATCH NOW : Craft a Winning Pricing Strategy to Maximize ARR Growth and Valuation Net Retention in Public Software Companies: Insights from the SEG SaaS Index We recently began tracking net retention information in our SEG SaaS Index , which tracks the performance of 120+ publicly traded software companies.

Valuation 52

Valuation Investors IT Management 52

Cooley M&A

JANUARY 25, 2023

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Novartis announced plans to spin off its generics and biosimilars division into a publicly traded stand-alone company. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Mergers and Inquisitions

DECEMBER 4, 2024

However, one common point across all the verticals is that IPOs are not common because there aren’t that many publicly traded sports teams, stadiums, or arenas. SPAC IPOs for esports companies were “hot” for a short period in 2021, but they seem to have died off by now.

Investment Banking 105

Investment Banking Bank Banking Investment 105

Cooley M&A

JANUARY 20, 2022

For example, early in 2021, Zimmer Biomet Holdings announced that it would spin off its spine and dental businesses into a new publicly traded company as a way to “optimize resource allocation” among its remaining businesses. Although the SPAC craze was (re)ignited in 2020, the volume of SPAC activity hit all?time time highs in 2021.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 25, 2023

The Securities and Exchange Commission’s universal proxy rules are now in effect, making it easier for shareholders to “mix-and-match” individual directors rather than having to choose a full slate. In addition to market forces, regulatory change is expected to spur activist activity in 2023.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Focus Investment Banking

FEBRUARY 11, 2025

Traditional terminal exit routes for private equity-backed companies are to larger strategic acquirers (often public companies) and IPOs, where a private company becomes publicly traded. By acquiring the providers themselves, McKesson is securing a customer and capturing profitability downstream from its current operations.

Private Equity 52

Private Equity Healthcare Equities Medical 52

Cooley M&A

JANUARY 22, 2025

This approach, combining M&A and initial public offering (IPO) preparations on parallel tracks, allows companies to maximize optionality in an uncertain market. Of course, the targets leverage in the M&A track of a dual-track process inherently increases when the IPO track is a viable strategy.

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64